Common use of Validation Review Clause in Contracts

Validation Review. In the event OIG has reason to believe that: (a) Halifax’s Arrangements Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifax’s final Annual Report shall be initiated no later than one year after Halifax’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax may request a meeting with OIG to: (a) discuss the results of any Arrangements Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review or Unallowable Cost Review issues with Halifax prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxCHSI’s Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review results are inaccurate (Validation Review). Halifax CHSI shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxCHSI’s final Annual Report shall be initiated no later than one year after HalifaxCHSI’s final submission (as described in Section II) is received by OIG. Community Health Systems, Inc. Corporate Integrity Agreement Prior to initiating a Validation Review, OIG shall notify Halifax CHSI of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax CHSI may request a meeting with OIG to: (a) discuss the results of any Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review or to correct the inaccuracy of the Inpatient Medical Necessity and Appropriateness Review , Arrangements Review Review, or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax CHSI agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.E.6in an expedited manner. OIG will attempt in good faith to resolve any Inpatient Medical Necessity and Appropriateness Review, Arrangements Review Review, or Unallowable Cost Review issues with Halifax CHSI prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: : (a) HalifaxKDMC’s Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review results are inaccurate (Validation Review). Halifax KDMC shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxKDMC’s final Annual Report shall be initiated no later than one year after HalifaxKDMC’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax KDMC of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax KDMC may request a meeting with OIG to: : (a) discuss the results of any Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review or to correct the inaccuracy of the Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax KDMC agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.E.6 in an expedited manner. OIG will attempt in good faith to resolve any Interventional Cardiac Procedures Review, Arrangements Review Review, or Unallowable Cost Review issues with Halifax KDMC prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxTCH’s Arrangements Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax TCH shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxTCH’s final Annual Report shall be initiated no later than one year after HalifaxTCH’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax TCH of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax TCH may request a meeting with OIG to: (a) discuss the results of any Arrangements Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax TCH agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review or Unallowable Cost Review issues with Halifax TCH prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxLWCI’s Arrangements Claims Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax LWCI shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxLWCI’s final Annual Report shall be initiated no later than one year after Halifax▇▇▇▇’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax LWCI of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax LWCI may request a meeting with OIG to: (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax LWCI agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax LWCI prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxOdyssey Hospice’s Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal Eligibility Review Team’s or IRO’s findings or Arrangements Review the Eligibility Review, Verification Review, or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review results are inaccurate (Validation Review). Halifax Odyssey Hospice shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifaxthe Odyssey Hospice’s final Annual Report shall be initiated no later than one year after HalifaxOdyssey Hospice’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax Odyssey Hospice of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax Odyssey Hospice may request a meeting with OIG to: (a) discuss the results of any Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax Odyssey Hospice agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.8 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review Eligibility Review, Verification Review, or Unallowable Cost Review issues with Halifax Odyssey Hospice prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.. Odyssey Corporate Integrity Agreement

Validation Review. In the event OIG has reason to believe that: (a) HalifaxHOTC’s Arrangements Eligibility Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Eligibility Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Eligibility Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Eligibility Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax HOTC shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxHOTC’s final Annual Report shall be initiated no later than one year after HalifaxHOTC’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax HOTC of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax HOTC may request a meeting with OIG to: (a) discuss the results of any Arrangements Eligibility Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Eligibility Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax HOTC agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Eligibility Review or Unallowable Cost Review issues with Halifax HOTC prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) Halifaxthe IRO’s Arrangements Review or Unallowable Cost Review, or the IRO’s Cardiac Catheterization Procedures Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements findings, Cardiac Catheterization Procedures Review or and/or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Cardiac Catheterization Procedures Review or and/or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements of the Cardiac Catheterization Procedures Review or and/or Unallowable Cost Review results are inaccurate (Validation Review). Halifax PRMC shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxPRMC’s final Annual Report shall be initiated no later than one year after HalifaxPRMC’s final submission (as described above in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax PRMC of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax PRMC may request a meeting with OIG to: (a) discuss the results of any Arrangements Cardiac Catheterization Procedures Review or and/or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Cardiac Catheterization Procedures Review or and/or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Cardiac Procedures Review or and/or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax PRMC agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Cardiac Catheterization Procedures Review or and/or Unallowable Cost Review issues with Halifax PRMC prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxPHC’s Arrangements Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax PHC shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxPHC’s final Annual Report shall be initiated no later than one year after HalifaxPHC’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax PHC of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax PHC may request a meeting with OIG to: (a) discuss the results of any Arrangements Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax PHC agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review or Unallowable Cost Review issues with Halifax PHC prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxHealthSouth’s Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement fails to conform to the requirements of this CIAAgreement; or (b) the Legal IRO’s findings or Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement complied with the requirements of the CIA Agreement and/or the findings or Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement results are inaccurate (Validation Review). Halifax HealthSouth shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxHealthSouth’s final Annual Report shall must be initiated no later than one year after HalifaxHealthSouth’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax HealthSouth of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax HealthSouth may request a meeting with OIG to: (a) discuss the results of any Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement or to correct the inaccuracy of the Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review, or Billing Engagement; and/or (c) propose alternatives to the proposed Validation Review. Halifax HealthSouth agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review or Cost Reporting Engagement, Unallowable Cost Review Review, or Billing Engagement issues with Halifax HealthSouth prior to conducting a Validation Review. Corporate Integrity Agreement HealthSouth Corporation However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) Halifax’s Arrangements All Smiles’ Claims Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax All Smiles shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifax’s All Smiles’ final Annual Report shall be initiated no later than one year after Halifax’s All Smiles’ final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax All Smiles of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax All Smiles may request a meeting with OIG to: : (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax All Smiles agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax All Smiles prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxVanguard’s Arrangements Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax Vanguard shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxVanguard’s final Annual Report shall be initiated no later than one year after HalifaxVanguard’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax Vanguard of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax Vanguard may request a meeting with OIG to: (a) discuss the results of any Arrangements Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax Vanguard agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.E.8 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review or Unallowable Cost Review issues with Halifax Vanguard prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxKai Heart’s Arrangements Claims Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax Kai Heart shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifax▇▇▇ ▇▇▇▇▇’s final Annual Report shall be initiated no later than one year after Halifax▇▇▇ ▇▇▇▇▇’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax Kai Heart of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax ▇▇▇ ▇▇▇▇▇ may request a meeting with OIG to: : (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax ▇▇▇ ▇▇▇▇▇ agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax ▇▇▇ ▇▇▇▇▇ prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxeTEL-Rx’s Arrangements Claims Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax eTEL-Rx shall pay for the reasonable cost of eTEL-Rx Corporate Integrity Agreement any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxeTEL-Rx’s final Annual Report shall be initiated no later than one year after HalifaxeTEL-Rx’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax eTEL-Rx of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax eTEL-Rx may request a meeting with OIG to: (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax ▇▇▇▇-▇▇ agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax eTEL-Rx prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) Halifax’s ▇▇▇▇▇▇▇▇’▇ Arrangements Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax ▇▇▇▇▇▇▇▇ shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifax’s ▇▇▇▇▇▇▇▇’▇ final Annual Report shall be initiated no later than one year after Halifax’s ▇▇▇▇▇▇▇▇’▇ final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax ▇▇▇▇▇▇▇▇ of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax ▇▇▇▇▇▇▇▇ may request a meeting with OIG to: : (a) discuss the results of any Arrangements Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax ▇▇▇▇▇▇▇▇ agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Review or Unallowable Cost Review issues with Halifax ▇▇▇▇▇▇▇▇ prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) HalifaxSound’s Arrangements Claims Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax Sound shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxSound’s final Annual Report shall be initiated no later than one year after HalifaxSound’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax Sound of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax Sound may request a meeting with OIG to: (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax Sound agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax Sound prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) Halifaxany of Pediatrix’s Arrangements Review Claims Reviews or an Unallowable Cost Review fails to conform to the requirements of this CIAAgreement; or (b) the Legal IRO’s findings or Arrangements Claims Review results or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or and/or Unallowable Cost Review complied with the requirements of the CIA Agreement and/or the findings or Arrangements Claims Review results or Unallowable Cost Review results are inaccurate (Validation Review). Halifax Pediatrix shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of HalifaxPediatrix’s final Annual Report shall must be initiated no later than one year after HalifaxPediatrix’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax Pediatrix of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax Pediatrix may request a meeting with OIG to: (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax Pediatrix agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax Pediatrix prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) Halifax▇▇▇▇▇▇▇▇▇▇ Regional’s Arrangements Claims Review or Unallowable Cost Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA and/or the findings or Arrangements Claims Review or Unallowable Cost Review results are inaccurate (Validation Review). Halifax ▇▇▇▇▇▇▇▇▇▇ Regional shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifax▇▇▇▇▇▇▇▇▇▇ Regional’s final Annual Report shall be initiated no later than one year after Halifax▇▇▇▇▇▇▇▇▇▇ Regional’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax ▇▇▇▇▇▇▇▇▇▇ Regional of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax ▇▇▇▇▇▇▇▇▇▇ Regional may request a meeting with OIG to: (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax ▇▇▇▇▇▇▇▇▇▇ Regional agrees to provide any additional information as may be requested by OIG under this Section III.E.5 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements Claims Review or Unallowable Cost Review issues with Halifax ▇▇▇▇▇▇▇▇▇▇ Regional prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Validation Review. In the event OIG has reason to believe that: (a) Halifax’s Arrangements Review or Unallowable Cost PolyMedica's Claims Review fails to conform to the requirements of this CIAAgreement; or (b) the Legal IRO’s 's findings or Arrangements Claims Review results or Unallowable Cost Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Arrangements Claims Review or Unallowable Cost Review complied with the requirements of the CIA Agreement and/or the findings or Arrangements Claims Review results or Unallowable Cost Review results are inaccurate (Validation Review). Halifax PolyMedica shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of Halifax’s PolyMedica's final Annual Report shall must be initiated no later than one year after Halifax’s PolyMedica's final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify Halifax PolyMedica of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, Halifax PolyMedica may request a meeting with OIG to: (a) discuss the results of any Arrangements Claims Review or Unallowable Cost Review submissions or findings; (b) present any additional information to clarify the results of the Arrangements Claims Review or Unallowable Cost Review or to correct the inaccuracy of the Arrangements Claims Review or Unallowable Cost Review; and/or (c) propose alternatives to the proposed Validation Review. Halifax PolyMedica agrees to provide any additional information as may be requested by OIG under this Section III.E.5 in an expedited manner. OIG will attempt in good faith to resolve any Arrangements POLYMEDICA CORPORATE INTEGRITY AGREEMENT Claims Review or Unallowable Cost Review issues with Halifax PolyMedica prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.